JournalArta
Wednesday, November 18, 2026 · JakartaS&P 7,340.53 ▼1.03%USD/IDR 18,245 ▼0.09%
JournalArta
Global Edition
beyond headlines
Advertisement

Oracle (ORCL) Stock Slides 3.43% (November 17, 2026): Down 12.3% in a Month

Technical analysis of ORCL stock on November 17, 2026: price 115.00 USD, trend downtrend, RSI 40.0, support 115.00, resistance 144.54.

By Elena Vance
November 18, 20265 min read
Oracle (ORCL) Stock Slides 3.43% (November 17, 2026): Down 12.3% in a Month
Oracle (ORCL) Stock Slides 3.43% (November 17, 2026)

Why ORCL is in focus today

  • Closed at a 20-day low (115.00)
  • MACD histogram has just turned negative
  • Downtrend extending (5-day change -2.53%)

Selected automatically from 80 NYSE (US) stocks by a technical-signal score with daily weighted randomisation — not a recommendation.

Oracle’s Tuesday close lands squarely on the fault line of its recent range — a test international investors should watch closely. The stock finished the November 17, 2026 session at $115.00, down 3.43% on the day, and exactly at its 20-day support. That is the lowest close of the past 20 sessions, and the tape says the seller still holds the pen. The fall is not a one-day event. Over five sessions Oracle has given up 2.53%, and across a month the loss runs to 12.31%. None of the three selection signals from JournalArta’s screen is kind: a close at the 20-day floor, a MACD histogram that has just flipped negative, and a downtrend that keeps grinding lower. These are not independent accidents; they describe one consistent story of a stock losing altitude under persistent selling pressure.
Advertisement

Trend & Price Action

The structure is unambiguous. Oracle trades well below its 20-day moving average of $125.26 and further below its 50-day average of $134.92. There is no fresh moving-average cross — no golden or death cross to mark — but the arrangement itself is the message: the shorter average sits beneath the longer one, and on Tuesday the 20-day line fell 1.53% over five sessions. A falling short-term average inside a longer-term downtrend is the textbook definition of a stock still searching for a floor.
Price action chart of ORCL
3-month price action chart of ORCL: price, SMA20/50, Bollinger, support & resistance.
Context on scale: the three-month high stands at $170.70 against a low of $109.21, and Tuesday’s $115.00 leaves the stock at 0% of its 20-day range — pressed against the bottom of the band rather than hovering near the middle. The nearest overhead reference is the 20-day resistance at $144.54, a long way above the current price. The short version: buyers have not shown up in size at any point this month.
Advertisement

Oscillators & Momentum

Momentum is weak but not yet panicked — a distinction that matters. The 14-day RSI reads 40.0, technically neutral but drifting into the lower half of its range, which tells you selling is steady rather than climactic. Stochastic tells a sharper story: %K at 16.4 against %D at 27.5 puts the fast line deep in oversold territory, an early warning that a short-term bounce is possible even inside a downtrend. MACD refuses to endorse that hope. At -4.296 against a signal line of -4.170, the histogram sits at -0.126 and has only just turned negative — a fresh bearish tilt rather than an old, exhausted one.
Momentum chart of ORCL
Momentum chart of ORCL: RSI(14), MACD, Stochastic.
Advertisement
That combination — oversold Stochastic but freshly negative MACD — usually means relief rallies can appear without reversing the trend. JournalArta’s signal tally bears this out: zero bullish signals against three bearish, including a failed bounce into the 20-day average while price remains below the 50-day.

Volatility, Volume & Fundamentals

Volatility is wide and getting wider. The average true range is $8.64, or 7.5% of the price — a full day’s swing that demands respect from anyone sizing a position. The Bollinger bands are spread 23.8% apart and expanding, with %B at 16% — the price hugging the lower band at $110.33. Expanding bands plus a low %B means the market is paying up for movement, and the direction so far has been down. Volume complicates the picture. Tuesday’s 25.6 million shares came in at just 0.6× the 20-day average of 41.7 million — thin participation, and alongside a falling OBV, a sign that sellers are persistent but not yet in a rush to exit. For a global reader: thin volume on a breakdown can mean the floor is soft, not that it is safe. Fundamentally, the filings offer a contrast worth noting. Oracle reported quarterly revenue of $19.35 billion for the quarter ended August 31, 2026, up 29.6% from $14.93 billion a year earlier, and net income of $4.76 billion against $2.93 billion, with diluted EPS of $1.56, according to its SEC filing. It also filed a Form 8-K on November 4 reporting other material events. Strong top-line growth, yet a stock down 12.31% in a month — the market, not the income statement, is doing the talking right now.
Advertisement

Key Levels & Scenarios

Two lines matter. Support sits at $115.00, the 20-day floor already touched. A decisive close below that opens the path toward the three-month low of $109.21, with the $102.04 level — one and a half times ATR beneath the price — as the outer marker of an extended move. On the other side, the stock needs a close above the 20-day resistance at $144.54 before any recovery case carries weight; the $127.96 level, one and a half times ATR above, marks the first meaningful upside test. The balance of evidence favors patience over action. Oversold Stochastic argues against fresh selling at the low; a fresh negative MACD, falling OBV and expanding bands argue against buying the dip.
Advertisement

Technical Verdict: HOLD (wait & see)

HOLD (wait & see) is the call, consistent with JournalArta’s research score of -84 on a -100 to +100 scale. Three reasons carry the decision: price sits below its 50-day average of $134.92, the 20-day average is beneath the 50-day and falling, and the MACD histogram has just turned negative — with zero bullish signals offsetting them. The verdict is invalidated if price closes below the 20-day support at $115.00, which would confirm the breakdown rather than a pause. - Entry range: only on a confirmed close above $144.54 (20-day resistance) — not at the current level. - Exit target: $127.96 as the first objective in an upside scenario; the $109.21 three-month low in a downside break. - Stop protection: below $115.00; the distance to a wider stop is too great to justify a position, which is why the call stays on hold. For a non-trading reader: Oracle is a strong business whose shares are still sliding, and the technicals say wait for proof of a bottom before acting. *This is technical analysis, not investment advice.*
Advertisement

Summary Data ORCL

Last price115.00 USD
Change 1 day / 5 days / 1 month-3.43% / -2.53% / -12.31%
Trend / MA-crossdowntrend / none
SMA20 / SMA50125.26 / 134.92
RSI (14) / Stochastic %K40.0 / 16.4
Bollinger %B / ATR16% / 8.64
Support / Resistance 20 days115.00 / 144.54
Data as of18 November 2026 04:04 WIB
JournalArta research verdict (score)Hold (-84)

Disclaimer: This technical analysis is generated automatically from exchange data and indicators calculated by JournalArta, for information and education only. The verdict and the entry, target and stop-loss levels are not investment advice or a solicitation to buy or sell any security. Investment decisions and their risks rest solely with the reader.

Advertisement
Take the quizWhat Kind of Holiday Spender Are You? Take the Black Friday QuizStart →
Advertisement
Most Read
  1. 1U.S. Emergency Alert Test Nov. 17 Is Not a Power Outage
  2. 2DUP Chairman Lord Morrow Loses Wife and Daughter Within Hours in NI
  3. 3NASA’s Curiosity Rover Burst Open a Rock and Found Pure Sulfur
  4. 4Women With Autoimmune Diseases Wait About 4 Years for Diagnosis, Study Finds
  5. 5Stock Market Today: Dow Futures Slip as Nasdaq Futures Climb Before Earnings
Advertisement
Don't Miss

Latest News

All stories →
  1. Business · CompaniesNHS England Records 3,029 Patient Data Snooping IncidentsNov 18
  2. Markets · StocksPepsiCo (PEP) Stock Latest: Slides 3.01% on Tuesday, Down 1.1% in Five SessionsNov 18
  3. Lifestyle · Food & HealthSpain Joins 20 Countries in Obesity Reduction PledgeNov 18
  4. Markets · StocksVerisk Analytics (VRSK) Stock on Tuesday: Slides 3.50%, Trading Volume 2x NormalNov 18
  5. Advertisement
  6. Markets · StocksWalt Disney (DIS) Stock Latest: Falls 1.48% on Tuesday, Trading Volume 2.3x NormalNov 18
  7. Markets · StocksGoldman Sachs (GS) Stock Falls 1.57%: Down 3.6% in Five SessionsNov 18
  8. Sport · More SportsCFP Rankings Keep Alabama at No. 3 Despite Six Losses by Beaten TeamsNov 18
  9. Lifestyle · EntertainmentCharlotte Gainsbourg Says Her Family’s Beauty Standards Left Her Feeling UglyNov 18